Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue sup2
Submit an article Journal homepage
1,378
Views
47
CrossRef citations to date
0
Altmetric
Articles

Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence

Monica ElseThe Institute of Cancer Research and the Royal Marsden NHS Trust, Sutton, UK
,
Claire E. DeardenThe Institute of Cancer Research and the Royal Marsden NHS Trust, Sutton, UK
,
Estella MatutesThe Institute of Cancer Research and the Royal Marsden NHS Trust, Sutton, UK
,
Francesco ForconiEmatologia e Trapianti, Dipartimento di Medicina clinica e Scienza Immunologiche, Università degli studi di Siena – AOUS, Siena, Italy
,
Francesco LauriaEmatologia e Trapianti, Dipartimento di Medicina clinica e Scienza Immunologiche, Università degli studi di Siena – AOUS, Siena, Italy
,
Humayun AhmadBurton Hospitals NHS Trust, Burton upon Trent, UK
,
Susan KellyBuckinghamshire Hospitals NHS Trust, High Wycombe, UK
,
Anandika LiyanageEast Kent Hospitals University NHS Foundation Trust, Ashford, Kent, UK
,
Vijitha RatnayakeEast Kent Hospitals University NHS Foundation Trust, Ashford, Kent, UK
,
Jagadeesan ShankariBasildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, UK
,
Ioana WhalleyThe Ipswich Hospital NHS Trust, Ipswich, UK
&
Daniel CatovskyThe Institute of Cancer Research and the Royal Marsden NHS Trust, Sutton, UKCorrespondence[email protected]
 show all
Pages 75-78 | Published online: 19 Apr 2011

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Mehdi Dehghani, Ali Kashkooe, Nasrin Namdari, Reza Majidi, Mojtaba Karimi, Shirin Haghighat, Alireza Rezvani & Negar Safari. (2023) Long-term follow-up of patients with hairy cell leukemia in the south of Iran. Expert Review of Hematology 16:4, pages 289-295.
Read now
Montserrat López-Rubio & Jose Antonio Garcia-Marco. (2015) Current and emerging treatment options for hairy cell leukemia. OncoTargets and Therapy 8, pages 2147-2156.
Read now
Tadeusz Robak, Anna Wolska & Pawel Robak. (2015) Potential breakthroughs with investigational drugs for hairy cell leukemia. Expert Opinion on Investigational Drugs 24:11, pages 1419-1431.
Read now
Preetesh Jain, Aaron Polliack & Farhad Ravandi. (2015) Novel therapeutic options for relapsed hairy cell leukemia. Leukemia & Lymphoma 56:8, pages 2264-2272.
Read now
Faisal Basheer, David M Bloxham, Mike A Scott & George A Follows. (2014) Hairy cell leukemia – immunotargets and therapies. ImmunoTargets and Therapy 3, pages 107-120.
Read now
Zheng Z Topp & Alan Saven. (2014) Hairy cell leukemia: a ‘hair-raising’ update. Expert Review of Hematology 7:5, pages 659-669.
Read now
Estella Matutes. (2013) Orphan drugs for the treatment of hairy cell leukemia. Expert Opinion on Orphan Drugs 1:1, pages 21-31.
Read now

Articles from other publishers (40)

Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin, Hélène Gardeney, Laly Nsiala, Mathilde Vonfeld, Aurélia Chacon, Aurélien Pichon, Sabrina Bouyer, Caroline Baslé, Elodie Dindinnaud, Jean‐Claude Chomel, Anna Raimbault, Florence Borde‐Mougenot, Xavier Troussard & Cécile Tomowiak. (2023) Hairy cell leukemia with isolated bone lesions. Clinical Case Reports 11:5.
Crossref
Mengqian Liu, Xiao Li, Meiyu Huai, Ying Yang & Caihong Dong. 2023. Fungi and Fungal Products in Human Welfare and Biotechnology. Fungi and Fungal Products in Human Welfare and Biotechnology 187 210 .
Claire Dearden. (2022) It’s a BRAF new world for hairy cell leukemia. Blood 140:25, pages 2649-2650.
Crossref
Xavier Troussard, Elsa Maître & Edouard Cornet. (2021) Hairy cell leukemia 2022: Update on diagnosis, risk‐stratification, and treatment. American Journal of Hematology 97:2, pages 226-236.
Crossref
Robert J. Kreitman & Evgeny Arons. (2022) Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. Blood Reviews 51, pages 100888.
Crossref
Martina Sollini, Francesco Bartoli, Sara Galimberti, Roberto Boni & Paola A. Erba. 2020. Nuclear Oncology. Nuclear Oncology 1 52 .
Martina Sollini, Francesco Bartoli, Sara Galimberti, Roberto Boni & Paola A. Erba. 2022. Nuclear Oncology. Nuclear Oncology 1329 1380 .
Raheel Siddiqui, Muhammad Sardar, Moazzam Shahzad, Jemin Jose, Insija Selene, Zunaira Shah, Anum Qureshi, Madeeha Shafqat, Rimsha Kashif, Maheen Ahmad, Alex Mejia-Garcia & Faiz Anwer. (2021) Management of Relapsed Hairy Cell Leukemia: A Systematic Review of Novel Agents and Targeted Therapies. Clinical Lymphoma Myeloma and Leukemia 21:10, pages 659-666.
Crossref
Rikhia Chakraborty, Omar Abdel-Wahab & Benjamin H. Durham. (2021) MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age. Cold Spring Harbor Perspectives in Medicine 11:5, pages a034892.
Crossref
Nilima Parry‐Jones, Anurag Joshi, Francesco Forconi & Claire Dearden. (2020) Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL‐V). British Journal of Haematology 191:5, pages 730-737.
Crossref
Claire Dearden & Sunil Iyengar. (2020) Hairy Cell Leukaemia: From Hairy Beginnings to a BRAF New World. British Journal of Haematology 191:4, pages 527-534.
Crossref
Matthew Cross & Claire Dearden. (2020) Hairy Cell Leukaemia. Current Oncology Reports 22:5.
Crossref
B. Wörmann. (2020) HaarzellleukämieHairy cell leukemia. Der Onkologe 26:3, pages 254-260.
Crossref
Elsa Maitre, Edouard Cornet & Xavier Troussard. (2019) Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. American Journal of Hematology 94:12, pages 1413-1422.
Crossref
Carmen F. Nobre, Matthew J. Newman, Anne DeLisa & Pauline Newman. (2019) Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations. Cancer Chemotherapy and Pharmacology 84:2, pages 255-263.
Crossref
Ji Won Lee, Youn Mi Choi, Jae Yun Yang, Seung Moon Han, Bong Seog Kim & Seung-Hyun Nam. (2018) Fludarabine and Rituximab in Relapsed or Refractory Hairy Cell Leukmia Variant: A Case Report and Review of Literature. Kosin Medical Journal 33:3, pages 438-445.
Crossref
Andreas Hanssønn Habberstad, Hoa Thi Tuyet Tran, Ulla Randen, Signe Spetalen, Ingunn Dybedal, Geir E. Tjønnfjord & Anders Erik Astrup Dahm. (2018) Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report. Journal of Medical Case Reports 12:1.
Crossref
Robert J. KreitmanMartin S. TallmanTadeusz RobakSteven CoutreWyndham H. Wilson, Maryalice Stetler-Stevenson, David J. FitzGeraldLinda Santiago, Guozhi Gao, Mark C. Lanasa & Ira Pastan. (2018) Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up. Blood 131:21, pages 2331-2334.
Crossref
Farhad Ravandi. 2018. Hematology. Hematology 1265 1276 .
Yazan F. Madanat, Lisa Rybicki, Tomas Radivoyevitch, Deepa Jagadeesh, Robert Dean, Brad Pohlman, Matt Kalaycio, Mikkael A. Sekeres, Mitchell R. Smith & Brian T. Hill. (2017) Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population. Clinical Lymphoma Myeloma and Leukemia 17:12, pages 857-862.
Crossref
Michael R. GreverOmar Abdel-WahabLeslie A. AndritsosVersha BanerjiJacqueline BarrientosJames S. BlachlyTimothy G. CallDaniel CatovskyClaire DeardenJudit DemeterMonica ElseFrancesco ForconiAlessandro GozzettiAnthony D. HoJames B. JohnstonJeffrey JonesGunnar JuliussonEric KrautRobert J. KreitmanLoree LarrattFrancesco LauriaGerard LozanskiEmili MontserratSameer A. ParikhJae H. ParkAaron PolliackGraeme R. QuestKanti R. RaiFarhad RavandiTadeusz RobakAlan SavenJohn F. SeymourTamar TadmorMartin S. TallmanConstantine TamEnrico TiacciXavier TroussardClive S. ZentThorsten Zenz, Pier Luigi Zinzani & Brunangelo Falini. (2017) Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood 129:5, pages 553-560.
Crossref
Martina Sollini, Sara Galimberti, Roberto Boni & Paola Anna Erba. 2017. Nuclear Oncology. Nuclear Oncology 1157 1195 .
M.A. Garza-Ledezma, C.A. Tellez-Hinojosa, E.E. González-López & D. Gómez-Almaguer. (2016) Hairy cell leukemia, an uncommon B-cell lymphoid neoplasia. Medicina Universitaria 18:70, pages 34-41.
Crossref
Martina Sollini, Sara Galimberti, Roberto Boni & Paola Anna Erba. 2016. Nuclear Oncology. Nuclear Oncology 1 39 .
Nadav Sarid, Humayun N Ahmad, Andrew Wotherspoon, Claire E Dearden, Monica Else & Daniel Catovsky. (2015) An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy. British Journal of Haematology 171:5, pages 784-787.
Crossref
Bartlomiej M. Getta, Jae H. Park & Martin S. Tallman. (2015) Hairy cell leukemia: Past, present and future. Best Practice & Research Clinical Haematology 28:4, pages 269-272.
Crossref
Monica Else, Claire E. Dearden & Daniel Catovsky. (2015) Long-term follow-up after purine analogue therapy in hairy cell leukaemia. Best Practice & Research Clinical Haematology 28:4, pages 217-229.
Crossref
T. Robak, E. Matutes, D. Catovsky, P.L. Zinzani & C. Buske. (2015) Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 26, pages v100-v107.
Crossref
S. Dietrich, M. Andrulis & T. Zenz. (2015) HaarzellleukämieHairy cell leukemia. Der Internist 56:4, pages 381-390.
Crossref
Ipek Yonal-Hindilerden, Fehmi Hindilerden, Sanem Bulut-Dereli, Eren Yıldız, Ibrahim Oner Dogan & Meliha Nalcaci. (2015) Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature. Case Reports in Hematology 2015, pages 1-8.
Crossref
Mathieu Leclerc, Felipe Suarez, Marie-Pierre Noël, Anne Vekhoff, Xavier Troussard, Jean-François Claisse, Catherine Thieblemont, Frédéric Maloisel, Yves Beguin, Jérôme Tamburini, Coralie Barbe & Alain Delmer. (2014) Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases. Annals of Hematology 94:1, pages 89-95.
Crossref
Edouard Cornet, C?cile Tomowiak, Aline Tanguy-Schmidt, St?phane Lepretre, Jehan Dupuis, Pierre Feugier, Alain Devidas, Clara Mariette, V?ronique Leblond, Catherine Thi?blemont, Patricia Validire-Charpy, Laurent Sutton, Emmanuel Gyan, Jean-Claude Eisenmann, Pascale Cony-Makhoul, Lo?c Ysebaert & Xavier Troussard. (2014) Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia. British Journal of Haematology 166:3, pages 390-400.
Crossref
Preetesh Jain, Naveen Pemmaraju & Farhad Ravandi. (2014) Update on the Biology and Treatment Options for Hairy Cell Leukemia. Current Treatment Options in Oncology 15:2, pages 187-209.
Crossref
V Maevis, U Mey, G Schmidt-Wolf & I G H Schmidt-Wolf. (2014) Hairy cell leukemia: short review, today’s recommendations and outlook. Blood Cancer Journal 4:2, pages e184-e184.
Crossref
Joshua D. Rosenberg, Carol Burian, Jill Waalen & Alan Saven. (2014) Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series. Blood 123:2, pages 177-183.
Crossref
Robert J. Kreitman. (2012) Immunoconjugates and new molecular targets in hairy cell leukemia. Hematology 2012:1, pages 660-666.
Crossref
Estella MatutesMonica Else & Daniel Catovsky. (2012) B-cell prolymphocytic leukemia and hairy cell leukemia: new advances in biology and treatment. International Journal of Hematologic Oncology 1:2, pages 159-167.
Crossref
Monica Else, Ana Marín‐Niebla, Fátima de la Cruz, Paul Batty, Eduardo Ríos, Claire E. Dearden, Daniel Catovsky & Estella Matutes. (2012) Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma. British Journal of Haematology 159:3, pages 322-328.
Crossref
Gail Jones, Nilima Parry-Jones, Bridget Wilkins, Monica Else & Daniel Catovsky. (2012) Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*. British Journal of Haematology 156:2, pages 186-195.
Crossref
Rahul R. Naik & Alan Saven. (2012) My Treatment Approach to Hairy Cell Leukemia. Mayo Clinic Proceedings 87:1, pages 67-76.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.